康美药业: 康美药业第十届董事会2025年度第三次临时会议决议公告

Group 1 - The board of directors of Kangmei Pharmaceutical Co., Ltd. held its third temporary meeting of the 2025 fiscal year on July 16, 2025, with all nine directors present, ensuring compliance with relevant laws and regulations [1][2] - The board approved a resolution regarding the signing of a settlement agreement and related party transactions, with a voting result of 6 in favor, 0 against, and 0 abstentions, while related directors recused themselves from the vote [1]